Reuters logo
4 个月前
BRIEF-Therapix Biosciences names Josh Blacher CFO
2017年5月3日 / 下午12点54分 / 4 个月前

BRIEF-Therapix Biosciences names Josh Blacher CFO

May 3 (Reuters) - Therapix Biosciences Ltd:

* Therapix Biosciences announces the appointment of Josh Blacher as chief financial officer

* Prior to joining Therapix, Blacher served as Chief Financial Officer at Galmed Pharmaceuticals Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below